Federated Hermes’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-16
| Closed | -$1K | – | 2414 |
|
|
2020
Q3 | $1K | Sell |
16
-50
| -76% | -$3.09K | ﹤0.01% | 2236 |
|
|
2020
Q2 | $4K | Buy |
66
+34
| +106% | +$1.97K | ﹤0.01% | 2034 |
|
|
2020
Q1 | $2K | Buy |
+32
| New | +$1.82K | ﹤0.01% | 2056 |
|
|
2019
Q4 | – | Sell |
-7
| Closed | -$1K | – | 2351 |
|
|
2019
Q3 | $1K | Sell |
7
-400
| -98% | -$23.3K | ﹤0.01% | 2172 |
|
|
2019
Q2 | $24K | Sell |
407
-48
| -11% | -$3.02K | ﹤0.01% | 1780 |
|
|
2019
Q1 | $28K | Sell |
455
-30
| -6% | -$1.98K | ﹤0.01% | 1725 |
|
|
2018
Q4 | $29K | Sell |
485
-160
| -25% | -$9.56K | ﹤0.01% | 1714 |
|
|
2018
Q3 | $38K | Sell |
645
-181
| -22% | -$9.23K | ﹤0.01% | 1776 |
|
|
2018
Q2 | $37K | Buy |
826
+520
| +170% | +$22.4K | ﹤0.01% | 1731 |
|
|
2018
Q1 | $14K | Buy |
+306
| New | +$12.9K | ﹤0.01% | 1825 |
|
|
2017
Q3 | – | Sell |
-121
| Closed | -$6K | – | 2214 |
|
|
2017
Q2 | $6K | Sell |
121
-188
| -61% | -$9.85K | ﹤0.01% | 1930 |
|
|
2017
Q1 | $17K | Buy |
+309
| New | +$16.4K | ﹤0.01% | 1761 |
|
|
2015
Q4 | – | Sell |
-175
| Closed | -$8K | – | 2184 |
|
|
2015
Q3 | $8K | Buy |
+175
| New | +$9.44K | ﹤0.01% | 1746 |
|
|
2015
Q2 | – | Sell |
-7
| Closed | -$1K | – | 2114 |
|
|
2015
Q1 | $1K | Sell |
7
-109
| -94% | -$4.27K | ﹤0.01% | 1986 |
|
|
2014
Q4 | $4K | Sell |
116
-191
| -62% | -$7.29K | ﹤0.01% | 1876 |
|
|
2014
Q3 | $11K | Sell |
307
-95
| -24% | -$2.79K | ﹤0.01% | 1731 |
|
|
2014
Q2 | $11K | Buy |
+402
| New | +$10.5K | ﹤0.01% | 1727 |
|
Other funds holding BSTC
Federated Hermes's BSTC Position: Q4 2020 in Review
Federated Hermes sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 16 shares — an estimated $1K sold.
Federated Hermes first reported a position in BSTC in Q2 2014 and held it in 17 quarters. The position peaked at $38K in Q3 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Federated Hermes reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Federated Hermes sold 16 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1K.
- Federated Hermes first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 17 quarters.
- Federated Hermes's BioSpecifics Technologies Corp. position peaked at $38K in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.